It's been a good week for Quest Diagnostics Incorporated ( NYSE:DGX ) shareholders, because the company has just... DXCM's third-quarter 2024 earnings and revenues surpass expectations ...

Below is Validea's guru fundamental report for QUEST DIAGNOSTICS INC (DGX). Of the 22 guru strategies we follow, DGX rates highest using our Multi-Factor Investor model based on the published ...

DGX has been the subject of several other research reports. Piper Sandler increased their target price on Quest Diagnostics from $145.00 to $150.00 and gave the company a “neutral” rating in a ...

Quest Diagnostics Inc.’s DGX third-quarter revenue growth can be attributed to the strong momentum in its expanding portfolio of Advanced Services. The company strategically deploys AI and ...

Quest Diagnostics Incorporated’s DGX third-quarter 2024 adjusted earnings per share (EPS) of $2.30 beat the Zacks Consensus Estimate by 1.8%. The metric also exceeded the year-ago adjusted ...

Post-Covid growth trends have normalized and the share price of DGX appears to be rising off of a long-term bottom. DGX is a relatively low volatility, conservative investment, promising 10% ...

Shares of DGX stock opened at $155.04 on Wednesday. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.00 and a quick ratio of 0.91. Quest Diagnostics has a one year low of $123. ...